The Oncology Institute, Inc. (NASDAQ:TOI) Major Shareholder Havencrest Healthcare Partners Sells 24,915 Shares of Stock

The Oncology Institute, Inc. (NASDAQ:TOI – Get Free Report) major shareholder Havencrest Healthcare Partners sold 24,915 shares of the firm’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $2.30, for a total value of $57,304.50. Following the completion of the sale, the insider now directly owns […]

Related Keywords

United States ,American , ,Institutional Investors Weigh In On Oncology Institute ,American International Group Inc ,Susquehanna International Group ,Patient Services ,Vanguard Personalized Indexing Management ,Nasdaq ,Securities Exchange Commission ,Morgan Stanley ,News Ratings For Oncology Institute Daily ,Oncology Institute Inc ,Oncology Institute Price Performance ,Oncology Institute Company Profile ,Oncology Institute ,Get Free Report ,Havencrest Healthcare Partners ,Exchange Commission ,Healthcare Partners ,Personalized Indexing Management ,International Group ,Street Group ,American International Group ,Clinical Trials ,Oncology Institute Daily ,Nasdaq Toi ,Toi ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,